Suppr超能文献

subsp. ,一种新兴的多药耐药细菌,是癌症患者败血症的病原体。

subsp. , an emerging multidrug-resistant bacterium, as a causative agent of septicaemia in cancer patients.

机构信息

Department of Laboratory Medicine, Division of Microbiology, Delhi State Cancer Institute, New Delhi, India.

Department of Clinical Oncology, Delhi State Cancer Institute, New Delhi, India.

出版信息

Indian J Med Res. 2017 Sep;146(3):420-425. doi: 10.4103/ijmr.IJMR_1362_15.

Abstract

Staphylococcus hominis subsp. novobiosepticus is a new sub-species of S. hominis, thus dividing S. hominis into subsp. hominis and novobiosepticus. This study was designed to identify subsp. novobiosepticus isolates amongst the S. hominis isolated from blood samples of patients with malignancy and septicaemia and to study their resistance profile. The identification was performed by using three simple tests which differentiated between the two sub-species. It was found that 22.8 per cent of S. hominis isolates belonged to subsp. novobiosepticus.

摘要

人葡萄球菌亚种新生亚种是一种新型的人葡萄球菌亚种,因此将人葡萄球菌分为人亚种和新生亚种。本研究旨在鉴定分离自恶性肿瘤和败血症患者血液样本中的人葡萄球菌亚种新生亚种分离株,并研究其耐药谱。通过使用三种简单的测试来区分这两个亚种,完成了鉴定。结果发现,22.8%的人葡萄球菌分离株属于新生亚种。

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验